1. Home
  2. SNOA vs ULY Comparison

SNOA vs ULY Comparison

Compare SNOA & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • ULY
  • Stock Information
  • Founded
  • SNOA 1999
  • ULY 2013
  • Country
  • SNOA United States
  • ULY United States
  • Employees
  • SNOA N/A
  • ULY N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • SNOA Health Care
  • ULY
  • Exchange
  • SNOA Nasdaq
  • ULY Nasdaq
  • Market Cap
  • SNOA 6.5M
  • ULY 5.8M
  • IPO Year
  • SNOA 2007
  • ULY N/A
  • Fundamental
  • Price
  • SNOA $3.76
  • ULY $2.53
  • Analyst Decision
  • SNOA
  • ULY Strong Buy
  • Analyst Count
  • SNOA 0
  • ULY 2
  • Target Price
  • SNOA N/A
  • ULY $11.50
  • AVG Volume (30 Days)
  • SNOA 53.7K
  • ULY 87.1K
  • Earning Date
  • SNOA 11-04-2025
  • ULY 11-12-2025
  • Dividend Yield
  • SNOA N/A
  • ULY N/A
  • EPS Growth
  • SNOA N/A
  • ULY N/A
  • EPS
  • SNOA N/A
  • ULY N/A
  • Revenue
  • SNOA $16,937,000.00
  • ULY $131,235,000.00
  • Revenue This Year
  • SNOA $23.00
  • ULY N/A
  • Revenue Next Year
  • SNOA $24.59
  • ULY $20.23
  • P/E Ratio
  • SNOA N/A
  • ULY N/A
  • Revenue Growth
  • SNOA 25.02
  • ULY N/A
  • 52 Week Low
  • SNOA $1.75
  • ULY $2.41
  • 52 Week High
  • SNOA $6.92
  • ULY $17.99
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 43.03
  • ULY 32.15
  • Support Level
  • SNOA $3.73
  • ULY $2.64
  • Resistance Level
  • SNOA $4.01
  • ULY $3.07
  • Average True Range (ATR)
  • SNOA 0.22
  • ULY 0.23
  • MACD
  • SNOA -0.00
  • ULY 0.00
  • Stochastic Oscillator
  • SNOA 44.32
  • ULY 13.41

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: